My guess is, if you are a long term investor -- it's probably a good time to pounce on the stock.
Most people don't think the bill will pass this year -- it's just a reminder of how much political rhetoric and pressure there is during an election year.
There are a lot of asthma pills out there, but this may be the best one yet. It has a benign side-effect profile and high efficiency.
Drug stocks are doing great today and they've been doing phenomenally well all year. The drug group is growing earnings in the mid-teens, double the S&P 500.
It's hard to say if Viagra is a sure winner. Viagra is a wildcard.